It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

A task force of law enforcement officials in Louisiana was able to confiscate thousands of pain pills after information was ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...

You cannot treat diabetes on your own. Your doctor will help you make a diabetes treatment plan that is right for you. Toujeo is an injectable insulin medication for the treatment of diabetes ...

Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture ...